S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Orgenesis (ORGS) News Today

$0.50
-0.01 (-1.96%)
(As of 04/19/2024 ET)
SourceHeadline
investing.com logoOrgenesis secures $2.3 million investment and strategic partnership
investing.com - April 17 at 11:58 AM
finanznachrichten.de logoOrgenesis Inc.: Orgenesis Provides Year End Business Update
finanznachrichten.de - April 17 at 9:28 AM
globenewswire.com logoOrgenesis Provides Year End Business Update
globenewswire.com - April 15 at 5:07 PM
investing.com logoGermfree partners with Orgenesis to enhance CGT production
investing.com - April 11 at 7:22 PM
globenewswire.com logoGermfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
globenewswire.com - April 10 at 12:00 PM
globenewswire.com logoVered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
globenewswire.com - March 18 at 8:30 AM
globenewswire.com logoOrgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes
globenewswire.com - March 13 at 8:30 AM
globenewswire.com logoOrgenesis Inc. Announces $2.3 Million Private Placement
globenewswire.com - March 4 at 8:30 AM
globenewswire.com logoOrgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
globenewswire.com - February 29 at 8:30 AM
finance.yahoo.com logoOrgenesis Inc. (ORGS)
finance.yahoo.com - February 23 at 2:21 PM
morningstar.com logoOrgenesis Inc ORGS
morningstar.com - February 22 at 9:04 PM
msn.com logoEXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic
msn.com - January 31 at 10:11 AM
finance.yahoo.com logoOrgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic
finance.yahoo.com - January 31 at 10:11 AM
finance.yahoo.com logoOrgenesis Inc. (ORGS) Stock Historical Prices & Data - Yahoo Finance
finance.yahoo.com - January 8 at 2:42 PM
finance.yahoo.com logoAnalysts Expect Orgenesis Inc. (NASDAQ:ORGS) To Breakeven Soon
finance.yahoo.com - November 22 at 7:49 AM
finanznachrichten.de logoOrgenesis Inc.: Orgenesis Provides Business Update for the Third Quarter of 2023
finanznachrichten.de - November 15 at 8:44 PM
finance.yahoo.com logoOrgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM
finance.yahoo.com - November 14 at 9:23 AM
finance.yahoo.com logoOrgenesis Provides Business Update for the Third Quarter of 2023
finance.yahoo.com - November 13 at 5:46 PM
finance.yahoo.com logoOrgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering
finance.yahoo.com - November 8 at 10:26 AM
forbes.com logo6 Secrets Of Organizations That Successfully Adapt To Change
forbes.com - November 5 at 8:34 PM
finance.yahoo.com logoOrgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding
finance.yahoo.com - November 2 at 8:08 AM
finanznachrichten.de logoOrgenesis Inc.: Orgenesis Announces Withdrawal of Proposed Public Offering
finanznachrichten.de - October 31 at 8:11 AM
finance.yahoo.com logoOrgenesis Announces Withdrawal of Proposed Public Offering
finance.yahoo.com - October 30 at 11:20 PM
finance.yahoo.com logoOrgenesis Announces Proposed Underwritten Public Offering
finance.yahoo.com - October 30 at 6:20 PM
stockhouse.com logoCGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United States
stockhouse.com - September 21 at 9:35 AM
finance.yahoo.com logoCGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United States
finance.yahoo.com - September 21 at 9:35 AM
finance.yahoo.com logoOrgenesis Inc (ORGS): A Deep Dive into Its Performance Potential
finance.yahoo.com - August 28 at 1:02 PM
finance.yahoo.com logoIs Orgenesis (ORGS) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
finance.yahoo.com - August 28 at 1:02 PM
finance.yahoo.com logoOrgenesis (ORGS): A Value Trap in Disguise?
finance.yahoo.com - August 24 at 6:26 AM
abcnews.go.com logoHow to help Maui fire victims from afar: Organizations and efforts underway
abcnews.go.com - August 13 at 4:18 PM
finanznachrichten.de logoOrgenesis Inc.: Orgenesis Provides Business Update for Second Quarter of 2023
finanznachrichten.de - August 11 at 12:54 PM
finance.yahoo.com logoOrgenesis Provides Business Update for Second Quarter of 2023
finance.yahoo.com - August 11 at 12:54 PM
finance.yahoo.com logoOrgenesis Schedules Second Quarter 2023 Business Update Conference Call
finance.yahoo.com - August 10 at 9:57 AM
finanznachrichten.de logoOrgenesis Inc.: Orgenesis Appoints Finance Veteran Elliot Maltz as its Chief Financial Officer
finanznachrichten.de - July 13 at 5:43 PM
marketwatch.com logoOrgenesis Names Maltz Finance Chief as Reithinger Resigns >ORGS
marketwatch.com - July 13 at 12:42 PM
finance.yahoo.com logoOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief Financial Officer
finance.yahoo.com - July 13 at 12:42 PM
finance.yahoo.com logoOrgenesis Announces Name Change of Morgenesis Business Unit to Octomera
finance.yahoo.com - July 11 at 7:45 AM
finance.yahoo.com logoOrgenesis Inc. (NASDAQ:ORGS) On The Verge Of Breaking Even
finance.yahoo.com - June 15 at 7:51 AM
finance.yahoo.com logoOrgenesis and University of California, Davis Sign Partnership Agreement for Rollout of Cell and Gene Therapy Mobile Processing Units and Labs Throughout California
finance.yahoo.com - June 7 at 7:45 AM
finance.yahoo.com logoClaudia Zylberberg Appointed as Independent Board Member of POCare Business Subsidiary of Orgenesis
finance.yahoo.com - May 30 at 10:22 AM
benzinga.com logoOrgenesis Academy Graduates First Class of Cell and Gene Therapy Experts from theraCell Laboratories-backed Master's Program
benzinga.com - May 22 at 9:27 AM
finance.yahoo.com logoOrgenesis Academy Graduates First Class of Cell and Gene Therapy Experts from theraCell Laboratories-backed Master’s Program
finance.yahoo.com - May 22 at 9:27 AM
finance.yahoo.com logoOrgenesis to Participate in Benchmark’s 3rd Annual Healthcare House Call Virtual 1x1 Investor Conference on May 23, 2023
finance.yahoo.com - May 19 at 9:05 AM
finance.yahoo.com logoOrgenesis Announces Collaboration Agreement with SCTbio to Expand POCare Sites in the Czech Republic and Enhance Capabilities for the Production of Lentivirus Vectors
finance.yahoo.com - May 18 at 7:40 AM
finance.yahoo.com logoOrgenesis Provides Business Update for the First Quarter of 2023 and Reports Continued Progress on its POCare Strategy
finance.yahoo.com - May 10 at 5:19 PM
finance.yahoo.com logoOrgenesis Secures an Additional $5 Million Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Service Subsidiary
finance.yahoo.com - May 10 at 1:24 PM
forbes.com logoThe Secret To Sustainability For Non-profit Organizations
forbes.com - April 26 at 8:04 PM
finance.yahoo.com logoOrgenesis CEO Vered Caplan Featured in Keynote Series at INTERPHEX Conference to Discuss Innovations in Cell & Gene Therapy Manufacturing
finance.yahoo.com - April 25 at 9:17 AM
venturebeat.com logoCrowdStrike turns to managed XDR to help orgs navigate the cyber skills gap
venturebeat.com - April 22 at 1:47 PM
finance.yahoo.com logoOrgenesis Inc.'s (NASDAQ:ORGS) Share Price Is Matching Sentiment Around Its Revenues
finance.yahoo.com - April 19 at 6:03 PM
Get Orgenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ORGS and its competitors with MarketBeat's FREE daily newsletter.

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here. 

ORGS Media Mentions By Week

ORGS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ORGS
News Sentiment

0.21

0.51

Average
Medical
News Sentiment

ORGS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ORGS Articles
This Week

3

0

ORGS Articles
Average Week

Get Orgenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ORGS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ORGS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners